Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
McKinsey
Merck
Express Scripts
Baxter

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Johnson And Johnson Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for JOHNSON AND JOHNSON, and when can generic versions of JOHNSON AND JOHNSON drugs launch?

JOHNSON AND JOHNSON has nine approved drugs.

There is one US patent protecting JOHNSON AND JOHNSON drugs.

There are fifteen patent family members on JOHNSON AND JOHNSON drugs in eleven countries.

Summary for Johnson And Johnson
International Patents:15
US Patents:1
Tradenames:11
Ingredients:7
NDAs:9

Drugs and US Patents for Johnson And Johnson

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Johnson And Johnson VISINE L.R. oxymetazoline hydrochloride SOLUTION/DROPS;OPHTHALMIC 019407-001 Mar 31, 1989 OTC Yes Yes   Start Trial   Start Trial
Johnson And Johnson MECLAN meclocycline sulfosalicylate CREAM;TOPICAL 050518-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Johnson And Johnson VASCOR bepridil hydrochloride TABLET;ORAL 019002-003 Dec 28, 1990 DISCN No No   Start Trial   Start Trial
Johnson And Johnson ROGAINE (FOR MEN) minoxidil SOLUTION;TOPICAL 019501-002 Feb 9, 1996 OTC Yes Yes   Start Trial   Start Trial
Johnson And Johnson WOMEN'S ROGAINE minoxidil AEROSOL, FOAM;TOPICAL 021812-002 Feb 28, 2014 OTC Yes Yes 6,946,120   Start Trial Y   Start Trial
Johnson And Johnson ERYCETTE erythromycin SWAB;TOPICAL 050594-001 Feb 15, 1985 DISCN Yes No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Johnson And Johnson

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Johnson And Johnson VASCOR bepridil hydrochloride TABLET;ORAL 019002-003 Dec 28, 1990 RE30577   Start Trial
Johnson And Johnson MEN'S ROGAINE minoxidil AEROSOL, FOAM;TOPICAL 021812-001 Jan 20, 2006 6,946,120   Start Trial
Johnson And Johnson WOMEN'S ROGAINE minoxidil AEROSOL, FOAM;TOPICAL 021812-002 Feb 28, 2014 6,946,120   Start Trial
Johnson And Johnson VASCOR bepridil hydrochloride TABLET;ORAL 019002-001 Dec 28, 1990 RE30577   Start Trial
Johnson And Johnson VASCOR bepridil hydrochloride TABLET;ORAL 019002-002 Dec 28, 1990 RE30577   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Moodys
Colorcon
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.